Table 2.
Characteristics of SHFS participants with available PAI-1 and LTL in both examinations conducted in 1998–1999 and 2001–2003 (N = 475)
| Characteristics | Mean/percentage |
|---|---|
| Age, year | 39.9±14.6 |
| Males, n (%) | 179 (37.68) |
| Current smoking, n (%) | 184 (38.98) |
| Current drinking, n (%) | 293 (62.08) |
| Education, years | 12.4±2.0 |
| Body mass index, kg/m2 | 31.3±7.4 |
| Waist circumference, cm | 102.4±18.6 |
| SBP, mmHg | 123.2±15.4 |
| DBP, mmHg | 76.7±9.3 |
| FPG, mg/dL | 112.3±55.4 |
| Insulin, uU/mL | 23.1±25.7 |
| Total cholesterol, mg/dL | 183.6±34.2 |
| Triglycerides, mg/dL | 132.8±125.3 |
| LDL-C, mg/dL | 117.6±28.8 |
| HDL-C, mg/dL | 44.4±12.8 |
| eGFR, mL/min/1.73 m2 | 94.6±23.6 |
| LTL, T/S ratio | 1.19±0.54 |
| Log-PAI-1 | 3.64±0.90 |
SBP: systolic blood pressure; DBP: diastolic blood pressure; FPG: fasting plasma glucose; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; eGFR: estimated glomerular filtration rate; Log-PAI-1: log-transformed plasminogen activator inhibitor 1; LTL: leukocyte telomere length.